07/31/2014 | Mark Hillen
Might you soon take a skin cell from a patient with retinitis pigmentosa, roll it back to a pluripotent state, culture it to become retinal cells and trial gene therapy on it in vitro?
Population-level disease prophylaxis with statins has improved the lives of millions. But there has been some protest about this mass medication. Is the next battle not with disease, but with the press?
06/18/2014
One of the most debilitating microvascular complications of diabetes is diabetic retinopathy, the most important cause of blindness among working age adults in developed countries.
As the prevalence of diabetes increases worldwide, so too do the complications relating to it, such as diabetic macular edema (DME).
Diabetic macular edema (DME) poses a significant management dilemma for visual impairment.
Diabetic macular edema (DME) may occur when blood vessels leak contents into the macular region.
06/18/2014 | Sponsored by Alimera
Diabetic maculopathy is the most common cause of visual impairment in individuals with diabetes.
06/17/2014 | Mark Hillen
A head-mounted iPhone-based ophthalmoscope is the latest step in the rapidly evolving world of smartphone fundoscopy
05/19/2014 | Mark Hillen
What does analysis of the last five years of the literature on Stargardt Disease tell us about the priorities of the field and the major contributors to it?
05/19/2014
Sitting Down With Alice McPherson,founder of the Retina Research Foundation
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: